BioTelemetry, Inc. Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Stay long AI-capex winners into the peak, Stifel says despite bubble fears
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
BioTelemetry (BEAT) Tops Q2 EPS by 19c
July 30, 2020 4:16 PM EDTBioTelemetry (NASDAQ: BEAT) reported Q2 EPS of $0.35, $0.19 better than the analyst estimate of $0.16. Revenue for the quarter came in at $99.1 million versus the consensus estimate of $89.52 million.
President and CEO Commentary
Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented:
Due to the unwavering commitment of the entire BioTelemetry team, we continued to successfully navigate the current external... More
